Description
Product Overview
ISRIB A15 (also designated as ISR-IN-2) is a next-generation structural analog of ISRIB developed to resolve solubility and pharmacokinetic constraints while delivering enhanced potency. Acting directly at the intersection of cellular stress and translational control, A15 is a potent molecular stabilizer of the eukaryotic translation initiation factor 2B (eIF2B) decameric complex.
Under cellular stress conditions, phosphorylation of eIF2α acts as a competitive inhibitor of eIF2B, causing global suppression of mRNA translation and halting protein synthesis. ISRIB A15 binds with sub-nanomolar affinity at the β/δ subunit interface of eIF2B, functionally acting as a molecular staple that locks the complex into its active enzymatic conformation regardless of eIF2α phosphorylation status.
Key Research Applications
- Traumatic Brain Injury & Concussion Recovery: Evaluated in animal models of concussive trauma and CTE, where sustained ISR activation halts dendritic spine remodeling and working memory. Research demonstrates post-injury administration can reset elevated ISR signaling and restore cognitive performance.
- Age-Related Cognitive Decline & Neurodegeneration: Chronically elevated eIF2α phosphorylation in aging brain tissue impairs long-term potentiation (LTP). A15 enables research into restoring protein supply chains required for memory consolidation across models of Alzheimer’s, ALS, and frontotemporal dementia.
- eIF2B Structural Biology & Leukodystrophies: Investigated as a rescue compound in cellular models of Vanishing White Matter Disease (VWMD) and for cryo-EM characterization of eIF2B decamer assembly.
- Synaptic Plasticity & Memory Consolidation: Facilitates sustained synthesis of plasticity-associated proteins (BDNF, CaMKII, Arc) during persistent cellular stress without triggering pancreatic toxicity associated with broader PERK inhibition.
Chemical & Technical Specifications
- Chemical Name: N,N’-((1r,4r)-cyclohexane-1,4-diyl)bis(2-(3,4-dichlorophenoxy)acetamide)
- Synonyms: ISRIB A15, ISR-IN-2, ISRIB Analog 15
- Molecular Formula: C₂₂H₂₂Cl₄N₂O₄
- Molecular Weight: 520.23 g/mol
- Primary Target: eIF2B Activator (EC50 ≈ 0.8 nM, 6.25× more potent than ISRIB)
- Purity: ≥98.0% (HPLC)
- Form: White to off-white crystalline solid / powder
- Solubility: Soluble in DMSO
- Storage: 2°C to 8°C. For in vitro laboratory research use only.




